| 1 |
33881978 | Wnt/β-catenin Antagonists: Exploring New Avenues to Trigger Old Drugs in Alleviating Glioblastoma Multiforme. | 2022 |
2 |
| 2 |
35163465 | Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines. | 2022 Jan 28 |
2 |
| 3 |
35406647 | Lichen Secondary Metabolites Inhibit the Wnt/β-Catenin Pathway in Glioblastoma Cells and Improve the Anticancer Effects of Temozolomide. | 2022 Mar 23 |
2 |
| 4 |
35418757 | The Silencing of LncRNA-H19 Decreases Chemoresistance of Human Glioma Cells to Temozolomide by Suppressing Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Pathway [Retraction]. | 2022 |
1 |
| 5 |
35490896 | Mannose inhibits proliferation and promotes apoptosis to enhance sensitivity of glioma cells to temozolomide through Wnt/β-catenin signaling pathway. | 2022 Jul |
4 |
| 6 |
32529543 | LncRNA MIR155HG Promotes Temozolomide Resistance by Activating the Wnt/β-Catenin Pathway Via Binding to PTBP1 in Glioma. | 2021 Aug |
2 |
| 7 |
33169799 | [Corrigendum] FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of β‑catenin nuclear accumulation. | 2021 Jan |
1 |
| 8 |
33692860 | Forkhead box protein O3a promotes glioma cell resistance to temozolomide by regulating matrix metallopeptidase and β-catenin. | 2021 Apr |
4 |
| 9 |
34072831 | NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the β-Catenin/c-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition. | 2021 May 31 |
3 |
| 10 |
34328678 | LINC00511 facilitates Temozolomide resistance of glioblastoma cells via sponging miR-126-5p and activating Wnt/β-catenin signaling. | 2021 Sep |
2 |
| 11 |
34657141 | A positive feedback loop of lncRNA-RMRP/ZNRF3 axis and Wnt/β-catenin signaling regulates the progression and temozolomide resistance in glioma. | 2021 Oct 16 |
3 |
| 12 |
34887392 | HMGA1 stimulates MYH9-dependent ubiquitination of GSK-3β via PI3K/Akt/c-Jun signaling to promote malignant progression and chemoresistance in gliomas. | 2021 Dec 10 |
1 |
| 13 |
32102932 | Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma. | 2020 Feb 26 |
2 |
| 14 |
32439916 | LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma. | 2020 May 21 |
2 |
| 15 |
32575464 | A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation. | 2020 Jun 19 |
3 |
| 16 |
32918978 | Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP3R1/AKT/β-catenin pathway. | 2020 Nov 1 |
1 |
| 17 |
32943609 | Wnt/β-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma. | 2020 Sep 17 |
1 |
| 18 |
33087705 | RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt/β-catenin signaling pathway. | 2020 Oct 22 |
3 |
| 19 |
33271924 | Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries. | 2020 Dec 1 |
1 |
| 20 |
30980849 | miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2. | 2019 Jun 1 |
1 |
| 21 |
31229358 | Corrigendum to "β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species". [Cancer Lett. 435 (2018) 66-79]. | 2019 Oct 1 |
1 |
| 22 |
31406250 | Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide. | 2019 Oct |
1 |
| 23 |
31805126 | IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/β-catenin pathway. | 2019 |
1 |
| 24 |
29391808 | The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway. | 2018 |
2 |
| 25 |
29854309 | Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro. | 2018 Apr 27 |
1 |
| 26 |
29906532 | Combination with TMZ and miR-505 inhibits the development of glioblastoma by regulating the WNT7B/Wnt/β-catenin signaling pathway. | 2018 Sep 25 |
1 |
| 27 |
30081068 | β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species. | 2018 Oct 28 |
3 |
| 28 |
28260024 | FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of β-catenin nuclear accumulation. | 2017 Apr |
2 |
| 29 |
27081861 | KLF8 Promotes Temozolomide Resistance in Glioma Cells via β-Catenin Activation. | 2016 |
2 |
| 30 |
27423571 | Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line. | 2016 Aug 15 |
1 |
| 31 |
25991372 | Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma. | 2015 Sep |
4 |
| 32 |
26170223 | PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/β-catenin signaling pathway. | 2015 Nov |
2 |
| 33 |
23771630 | Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signaling. | 2014 Feb |
2 |
| 34 |
23230963 | Aspirin-/TMZ-coloaded microspheres exert synergistic antiglioma efficacy via inhibition of β-catenin transactivation. | 2013 Feb |
2 |
| 35 |
21887474 | Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways. | 2011 Nov |
1 |